Longeveron ends record rally with appointment of new medical chief

seekingalpha2022-04-06

ValleraTo/iStock via Getty Images After sharp gains last week, the clinical-stage biotech, Longeveron (LGVN -9.7%) closed lower for the second straight session on Tuesday after the company announced...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

masran
2022-04-06
masran
like pls

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2225953344?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-04-06 05:58","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2225953344","market":"us","top_or_hot":-1,"title":"Longeveron ends record rally with appointment of new medical chief","media":"seekingalpha","content":"<div>\n<p>ValleraTo/iStock via Getty Images   After sharp gains last week, the clinical-stage biotech, Longeveron (LGVN -9.7%) closed lower for the second straight session on Tuesday after the company announced...</p>\n\n<a href=\"https://seekingalpha.com/news/3820957-lgvn-stock-ends-record-rally-with-appointment-of-new-medical-chief\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Longeveron ends record rally with appointment of new medical chief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLongeveron ends record rally with appointment of new medical chief\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-06 05:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3820957-lgvn-stock-ends-record-rally-with-appointment-of-new-medical-chief><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ValleraTo/iStock via Getty Images   After sharp gains last week, the clinical-stage biotech, Longeveron (LGVN -9.7%) closed lower for the second straight session on Tuesday after the company announced...</p>\n\n<a href=\"https://seekingalpha.com/news/3820957-lgvn-stock-ends-record-rally-with-appointment-of-new-medical-chief\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/3820957-lgvn-stock-ends-record-rally-with-appointment-of-new-medical-chief","article_id":"2225953344","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2225953344","pubTimestamp":1649195931,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"ValleraTo/iStock via Getty Images   After sharp gains last week, the clinical-stage biotech, Longeveron  closed lower for the second straight session on Tuesday after the company announced the appointment of Chris Min as its Chief Medical Officer .  Longeveron  shares recorded the third-best weekly gain last week on the back of peer-reviewed data on its Alzheimer’s disease candidate Lomecel-B.  In an announcement Tuesday, the company said that its global R&D efforts would be led by Dr. Min effec","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LGVN":"Longeveron Inc"},"translate_title":"Longeveron结束创纪录的反弹，任命新的医疗主管","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LGVN":1},"content_text":"ValleraTo/iStock via Getty Images   After sharp gains last week, the clinical-stage biotech, Longeveron (LGVN -9.7%) closed lower for the second straight session on Tuesday after the company announced the appointment of Chris Min as its Chief Medical Officer (CMO).  Longeveron (NASDAQ:LGVN) shares recorded the third-best weekly gain last week on the back of peer-reviewed data on its Alzheimer’s disease candidate Lomecel-B.  In an announcement Tuesday, the company said that its global R&D efforts would be led by Dr. Min effective Monday. His role includes leadership on plans to advance the lead candidate Lomecel-B into pivotal stage trials and towards regulatory approval, the company added. “As a board-certified neurologist with deep clinical experience, Chris will be instrumental in guiding our Alzheimer’s development program,” Chief Executive Geoff Green said. Dr. Min joins Longeveron (LGVN) from Enterin Inc., where he served as the Head of Medical & Clinical Development.  See how company shares have performed during the year.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9016665595,"gmtCreate":1649194694562,"gmtModify":1676534465151,"author":{"id":"3582888796077977","authorId":"3582888796077977","name":"masran","avatar":"https://static.tigerbbs.com/5258de17f60ac17503ecfa2ededa974d","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"like pls","listText":"like pls","text":"like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016665595","repostId":2225953344,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2225953344"}